{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:11:56Z","timestamp":1790979116121,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejpb.2017.10.008","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T05:02:17Z","timestamp":1507957337000},"page":"54-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":142,"special_numbering":"C","title":["In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9755-0911","authenticated-orcid":false,"given":"Paola","family":"Mura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2439-2251","authenticated-orcid":false,"given":"Natascia","family":"Mennini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Nativi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Richichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2017.10.008_b0005","doi-asserted-by":"crossref","first-page":"17979","DOI":"10.1073\/pnas.0605865103","article-title":"Human opiorphin, a natural antinociceptive modulator of opioid-dependent pathways","volume":"103","author":"Wisner","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejpb.2017.10.008_b0010","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.peptides.2009.04.002","article-title":"Effects and underlying mechanisms of human opiorphin on colonic motility and nociception in mice","volume":"30","author":"Tian","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.ejpb.2017.10.008_b0015","unstructured":"C. Rougeot, Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases, Patent WO, 2009, 124948A1."},{"key":"10.1016\/j.ejpb.2017.10.008_b0020","first-page":"483","article-title":"Systemically active human opiorphin is a potent yet non-addictive analgesic without drug tolerance effects","volume":"61","author":"Rougeot","year":"2010","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejpb.2017.10.008_b0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbr.2010.04.045","article-title":"Human opiorphin: the lack of physiological dependence, tolerance to antinociceptive effects and abuse liability in laboratory mice","volume":"213","author":"Popik","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejpb.2017.10.008_b0030","unstructured":"N. Mennini, P. Mura, C. Nativi, B. Richichi, L. Di Cesare Mannelli, C. Ghelardini, Injectable liposomal formulations of opiorphin as a new therapeutic strategy in pain management, Fut. Sci. OA 1(3) (2015) 10.4155."},{"key":"10.1016\/j.ejpb.2017.10.008_b0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery: possibility, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2017.10.008_b0040","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4155\/tde.12.12","article-title":"Drug development of intranasally delivered peptides","volume":"3","author":"Campbell","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejpb.2017.10.008_b0045","first-page":"110","article-title":"Nasal drug delivery systems: an overview","volume":"3","author":"Ghori","year":"2015","journal-title":"Am. J. Pharmacol. Sci."},{"key":"10.1016\/j.ejpb.2017.10.008_b0050","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2017.10.008_b0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0169-409X(97)00059-8","article-title":"Nasal mucociliary clearance as a factor in nasal drug delivery","volume":"29","author":"Merkus","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2017.10.008_b0060","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.addr.2005.07.009","article-title":"Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives","volume":"57","author":"Ugwoke","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2017.10.008_b0065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/03639040903170750","article-title":"The application of mucoadhesive polymers in nasal drug delivery","volume":"36","author":"Jiang","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2017.10.008_b0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0168-3659(99)00271-0","article-title":"Evaluation of starch-maltodextrin-Carbopol 974 P mixtures for the nasal delivery of insulin in rabbits","volume":"66","author":"Callens","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2017.10.008_b0075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejpb.2006.05.017","article-title":"Nasal absorption of metoclopramide from different Carbopol 981 based formulations: in vitro, ex vivo and in vivo evaluation","volume":"64","author":"Tas","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.10.008_b0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/10717544.2013.849778","article-title":"Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation","volume":"21","author":"Galgatte","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2017.10.008_b0085","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0169-409X(01)00242-3","article-title":"Thermosensitive sol-gel reversible hydrogels","volume":"54","author":"Jeong","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2017.10.008_b0090","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejpb.2004.03.019","article-title":"In situ-forming hydrogels \u2013 review of temperature-sensitive systems","volume":"58","author":"Ruel-Gari\u00e9py","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2017.10.008_b0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-5173(97)00386-4","article-title":"Development of in-situ gelling and mucoadhesive acetaminophen liquid suppository","volume":"165","author":"Choi","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.10.008_b0100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijpharm.2012.03.054","article-title":"Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide","volume":"430","author":"Yuan","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.10.008_b0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0378-5173(01)00809-2","article-title":"Effect of sodium chloride on gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium","volume":"226","author":"Yong","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.10.008_b0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.carbpol.2014.11.065","article-title":"Amidated pectin-based wafers for econazole buccal delivery: formulation optimization and antimicrobial efficacy estimation","volume":"121","author":"Mura","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2017.10.008_b0115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10611860903386938","article-title":"Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats","volume":"18","author":"Khan","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2017.10.008_b0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijpharm.2004.07.044","article-title":"Development and bioadhesive properties of chitosan-ethylcellulose microspheres for nasal delivery","volume":"291","author":"Martinac","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.10.008_b0125","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1021\/cr030441b","article-title":"Chitosan chemistry and pharmaceutical perspectives","volume":"104","author":"Kumar","year":"2004","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejpb.2017.10.008_b0130","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1517\/17425247.2010.495981","article-title":"Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles","volume":"7","author":"Luppi","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2017.10.008_b0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1517\/17425247.2014.867326","article-title":"Thermosensitive chitosan\/glycerophosphate-based hydrogel and its derivatives in pharmaceutical and biomedical applications","volume":"11","author":"Supper","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2017.10.008_b0140","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.carbpol.2014.09.094","article-title":"Glycerophosphate-based chitosan thermosensitive hydrogels and their biomedical applications","volume":"117","author":"Zhou","year":"2015","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2017.10.008_b0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10971-006-9007-1","article-title":"Gelation time and degradation rate of chitosan-based injectable hydrogel","volume":"42","author":"Ganji","year":"2007","journal-title":"J. Solgel Sci. Technol."},{"key":"10.1016\/j.ejpb.2017.10.008_b0150","first-page":"466","article-title":"Development and evaluation of in situ nasal gel formulations of loratadine","volume":"10","author":"Sherafudeen","year":"2015","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2017.10.008_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v19.i1.10","article-title":"Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers","volume":"19","author":"Kabanov","year":"2002","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ejpb.2017.10.008_b0160","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/jcis.1997.4880","article-title":"Study of the gelation process of polyethylene oxide-polypropylene oxide-polyethylene oxide copolymer (poloxamer 407) aqueous solutions","volume":"190","author":"Cabana","year":"1997","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2017.10.008_b0165","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","article-title":"A review of poloxamer 407 pharmaceutical and pharmacological characteristics","volume":"23","author":"Dumortier","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2017.10.008_b0170","first-page":"991","article-title":"Mucoadhesive thermoreversible nasal delivery system","volume":"3","author":"Sharma","year":"2010","journal-title":"J. Pharm. Res."},{"key":"10.1016\/j.ejpb.2017.10.008_b0175","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2003.10.015","article-title":"Nasal delivery of levonorgestrel for contraception: an experimental study in rats","volume":"81","author":"Shahiwala","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ejpb.2017.10.008_b0180","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1081\/LPR-100108460","article-title":"Enhancement of nasal absorption of calcitonin loaded in liposomes","volume":"11","author":"Law","year":"2001","journal-title":"J. Lipos. Res."},{"key":"10.1016\/j.ejpb.2017.10.008_b0185","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/10611860701453653","article-title":"Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery","volume":"15","author":"Jain","year":"2007","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2017.10.008_b0190","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1248\/bpb.16.457","article-title":"Influence of liposomes on tryptic digestion of insulin","volume":"16","author":"Kato","year":"1993","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2017.10.008_b0195","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijpharm.2011.07.012","article-title":"A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment","volume":"419","author":"Xu","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.10.008_b0200","first-page":"15","article-title":"Optimization of a method to prepare liposomes containing HER2\/Neu-derived peptide as a vaccine delivery system for breast cancer","volume":"13","author":"Shariat","year":"2014","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.ejpb.2017.10.008_b0205","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1208\/s12249-010-9463-3","article-title":"The experimental design as a practical approach to develop and optimize a formulation of peptide-loaded liposomes","volume":"11","author":"Ducate","year":"2010","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.ejpb.2017.10.008_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5173(94)00245-Z","article-title":"Generation of contrast-carrying liposomes of defined size with a new continuous high pressure extrusion method","volume":"117","author":"Schneider","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.10.008_b0215","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijpharm.2011.11.036","article-title":"A quality by design (QbD) case study on liposomes containing hydrophilic API: II. Screening of critical variables, and establishment of design space at laboratory scale","volume":"423","author":"Xu","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.10.008_b0220","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2004.04.026","article-title":"Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density","volume":"98","author":"Vila","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2017.10.008_b0225","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijpharm.2004.09.002","article-title":"PLA-PEG particles as nasal vaccine carriers: influence of the particle size","volume":"292","author":"Vila","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.10.008_b0230","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.arcmed.2015.06.009","article-title":"Transfer of opiorphin through a blood-brain barrier culture model","volume":"46","author":"Bocsik","year":"2015","journal-title":"Arch. Med. Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117307026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117307026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T03:24:39Z","timestamp":1538018679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641117307026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":46,"alternative-id":["S0939641117307026"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.10.008","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}